7 completed. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 3 | Completed 3 |
Follow Egg Hypersensitivity: new trials by email Literature Review of Egg Hypersensitivity trials Research Report on Egg Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
| Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy Egg Oral Immunotherapy, Baked Egg - Food Allergy | Phase 2 | Completed | Hugh A Sampson, MD | 92 | 2013-07-01 | 2019-07-26 |
| Persistence of Oral Tolerance to Peanut Avoidance of peanut - Eczema, Egg Allergy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 556 | 2011-05-01 | 2017-03-10 |
| FluMist in Egg Allergic Patients FluMist intranasal influenza vaccine, Intramuscular influenza injection ("flu shot") - Egg Allergy, Eligible for Vaccination Against Influenza | Phase 1 / Phase 2 | Completed | Walter Reed Army Medical Center | 17 | 2010-09-01 | 2018-10-03 |
| Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy Specific oral tolerance induction - - Egg Hypersensitivity | Phase 1 / Phase 2 | Completed | Ospedale Buon Consiglio Fatebenefratelli | 20 | 2008-01-01 | 2011-09-20 |
| Oral Immunotherapy for Childhood Egg Allergy Egg oral immunotherapy, Control Group - Hypersensitivity, Immediate Hypersensitivity | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 55 | 2007-05-01 | 2017-12-13 |
| Promoting Tolerance to Peanut in High-Risk Children Peanut Consumption Group - Eczema, Egg Allergy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 640 | 2006-12-01 | 2019-04-17 |
Food Hypersensitivity (5) · Hypersensitivity (4) · Eczema (2) · Hypersensitivity, Immediate (2) · Peanut Hypersensitivity (2) · Anaphylaxis (1) · Immune System Diseases (1) · Influenza, Human (1) · Milk Hypersensitivity (1) · Nut Hypersensitivity (1) · Shellfish Hypersensitivity (1) · Wheat Hypersensitivity (1)
Immune System Diseases (6) · Hypersensitivity, Immediate (5) · Hypersensitivity (3) · Dermatitis (2) · Food Hypersensitivity (2) · Nut and Peanut Hypersensitivity (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Skin and Connective Tissue Diseases (2) · Infections (1) · Orthomyxoviridae Infections (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Afluria (1) · Control Groups (1) · FluLaval (1) · Influenza Vaccines (1) · fluarix (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Alladapt Immunotherapeutics, Inc. (1) · Hugh A Sampson, MD (1) · Ospedale Buon Consiglio Fatebenefratelli (1) · Walter Reed Army Medical Center (1)
United States (4) · United Kingdom (2) · Italy (1)
Gideon Lack, MD (2) · Robert Wood, MD (2) · David Fleischer, MD (1) · Hugh A Sampson, MD (1) · Iride Dello Iacono, pediatrician (1) · Mei-Lun Wang, MD (1) · Scott Sicherer, MD (1) · Stacie Jones, MD (1) · Susan Laubach, MD (1) · Wesley Burks, MD (1)
PMID 22808958, PMID 23174658, PMID 25705822, PMID 25705823, PMID 26924470, PMID 26942922, PMID 27297994, PMID 36521802, PMID 41615410
U19AI066738 (2)